MRNA Technology - Search News

FDA, mRNA and Moderna

Digest more

Scientific American · 9d

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots

· 2d · on MSN

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

BioSpace · 4d

Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait

Morning Overview on MSN

New mRNA flu shot proves 30%+ more powerful at stopping influenza A

Moderna says its experimental mRNA influenza vaccine, mRNA-1010, showed more than 30% greater relative vaccine efficacy against influenza A than a licensed egg-based flu shot in a large Phase 3 trial ...

BioSpace

Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA, mRNA and Moderna

New mRNA flu shot proves 30%+ more powerful at stopping influenza A

Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus

Trending now